Corient Private Wealth’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,468
Closed -$739K 2973
2025
Q4
$739K Buy
12,468
+6,242
+100% +$339K ﹤0.01% 2066
2025
Q3
$344K Buy
6,226
+2
+0% +$104 ﹤0.01% 2039
2025
Q2
$268K Sell
6,224
-837
-12% -$32.3K ﹤0.01% 2059
2025
Q1
$280K Buy
7,061
+246
+4% +$10.9K ﹤0.01% 1890
2024
Q4
$278K Sell
6,815
-4,600
-40% -$192K ﹤0.01% 1937
2024
Q3
$445K Buy
11,415
+6,827
+149% +$272K ﹤0.01% 1803
2024
Q2
$201K Sell
4,588
-204
-4% -$9.86K ﹤0.01% 2116
2024
Q1
$229K Buy
+4,792
New +$215K ﹤0.01% 2030
2023
Q2
Sell
-2,827
Closed -$202K 2130
2023
Q1
$202K Buy
+2,827
New +$224K ﹤0.01% 1799

Other funds holding NGVT

Corient Private Wealth's NGVT Position: Q1 2026 in Review

Corient Private Wealth sold out of Ingevity (NGVT) in Q1 2026, closing a stake of 12,468 shares — an estimated $739K sold.

Corient Private Wealth first reported a position in NGVT in Q1 2023 and held it in 9 quarters. The position peaked at $739K in Q4 2025. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Corient Private Wealth reported no remaining Ingevity position as of Q1 2026 after selling out during the quarter.
  • Corient Private Wealth sold 12,468 Ingevity shares in Q1 2026, an estimated $739K.
  • Corient Private Wealth first reported a position in Ingevity in Q1 2023 and held it in 9 quarters.
  • Corient Private Wealth's Ingevity position peaked at $739K in Q4 2025.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.